What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome

Qiang Li(Chinese Academy of Sciences), Qijian Yi(Children's Hospital of Chongqing Medical University), Hongyu Kuang(China International Science and Technology Cooperation), Tiewei Lu(China International Science and Technology Cooperation), Yuhao Wu(Westlake University)
Medicine
May 1, 2019
10.1097/md.0000000000015632
Cited by 9

Related Papers

Nesprin-1 and -2 are involved in the pathogenesis of Emery–Dreifuss muscular dystrophy and are critical for nuclear envelope integrity
|Human Molecular Genetics|2007|538
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
|The Lancet|2019|271
Rapamycin Enhances Mitophagy and Attenuates Apoptosis After Spinal Ischemia-Reperfusion Injury
|Frontiers in Neuroscience|2018|115
Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data
|Vox Sanguinis|2016|109
Genistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter region
|Oncotarget|2016|70